Authors:
Urayama, S
Kawakami, A
Nakashima, T
Yamasaki, S
Hida, A
Ida, H
Kamachi, M
Nakamura, H
Origuchi, T
Migita, K
Kawabe, Y
Eguchi, K
Citation: S. Urayama et al., New disease-modifying antirheumatic drug 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298) selectively augments activation-induced T cell death, J LA CL MED, 138(1), 2001, pp. 11-17
Authors:
Honda, S
Migita, K
Hirai, Y
Origuchi, T
Yamasaki, S
Kamachi, M
Shibatomi, K
Fukuda, T
Kita, M
Hida, A
Ida, H
Aoyagi, T
Kawakami, A
Kawabe, Y
Oizumi, K
Eguchi, K
Citation: S. Honda et al., Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells, CLIN EXP IM, 126(1), 2001, pp. 131-136
Authors:
Shibatomi, K
Ida, H
Yamasaki, S
Nakashima, T
Origuchi, T
Kawakami, A
Migita, K
Kawabe, Y
Tsujihata, M
Anderson, P
Eguchi, K
Citation: K. Shibatomi et al., A novel role for interleukin-18 in human natural killer cell death - High serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases, ARTH RHEUM, 44(4), 2001, pp. 884-892
Authors:
Tanaka, F
Origuchi, T
Migita, K
Tominaga, M
Kawakami, A
Kawabe, Y
Eguchi, K
Citation: F. Tanaka et al., Successful combined therapy of cyclophosphamide and cyclosporine for acuteexacerbated interstitial pneumonia associated with dermatomyositis, INTERN MED, 39(5), 2000, pp. 428-430
Authors:
Origuchi, T
Migita, K
Nakashima, T
Tominaga, M
Nakamura, H
Nakashima, M
Aoyagi, T
Kawakami, A
Kawabe, Y
Eguchi, K
Citation: T. Origuchi et al., IL-1-mediated expression of membrane type matrix-metalloproteinase in rheumatoid osteoblasts, CLIN EXP RH, 18(3), 2000, pp. 333-339
Authors:
Origuchi, T
Migita, K
Nakashima, T
Honda, S
Yamasaki, S
Hida, A
Kawakami, A
Aoyagi, T
Kawabe, Y
Eguchi, K
Citation: T. Origuchi et al., Regulation of cyclooxygenase-2 expression in human osteoblastic cells by N-acetylcysteine, J LA CL MED, 136(5), 2000, pp. 390-394
Authors:
Kamachi, M
Migita, K
Tominaga, M
Ichinose, Y
Nakamura, H
Origuchi, T
Urayama, S
Hida, A
Kawakami, A
Kawabe, Y
Taguchi, T
Eguchi, K
Citation: M. Kamachi et al., Sjogren's syndrome complicated by MPO-ANCA positive crescentic glomerulonephritis, NEPH DIAL T, 14(4), 1999, pp. 1033-1034
Authors:
Arahata, H
Migita, K
Izumoto, H
Miyashita, T
Munakata, H
Nakamura, H
Tominaga, M
Origuchi, T
Kawabe, Y
Hida, A
Taguchi, T
Eguchi, K
Citation: H. Arahata et al., Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins, CLIN RHEUMA, 18(1), 1999, pp. 77-81
Authors:
Tominaga, M
Migita, K
Nakamura, H
Ichinose, Y
Furuya, T
Origuchi, T
Kawabe, Y
Hida, A
Nakamura, T
Eguchi, K
Citation: M. Tominaga et al., Expression of metalloproteinase-2 (gelatinase A) in labial salivary glandsof patients with Sjorgren's syndrome with HTLV-I infection, CLIN EXP RH, 17(4), 1999, pp. 463-466
Authors:
Migita, K
Origuchi, T
Kawabe, Y
Tominaga, M
Ida, H
Kawakami, A
Eguchi, K
Citation: K. Migita et al., FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cellsby down-regulation of Bcl-x(L), TRANSPLANT, 68(7), 1999, pp. 1018-1023
Authors:
Kawakami, A
Tsuboi, M
Urayama, S
Matsuoka, N
Yamasaki, S
Hida, A
Aoyagi, T
Furuichi, I
Nakashima, T
Migita, K
Kawabe, Y
Nakashima, M
Origuchi, T
Eguchi, K
Citation: A. Kawakami et al., Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells, J LA CL MED, 133(6), 1999, pp. 566-574